Prevalence and Determinants of Significant Liver Fibrosis by Vibration-Controlled Transient Elastography in Thai Chronic Hepatitis B Patients

Table 1

Demographic and laboratory data of patients.

Variable	Value
Total patients with a valid transient elastography scan, n	206
Liver stiffness, median (range), kPa	5.50 (2.50-63.90)
Interquartile range, median (range)	11.00 (1.40-24.60)
Failed scan, n (%)	3 (1.3)
Success rate, %	98.7
Treatment naïve patients, n (%)	206 (100.0)
Age, mean (SD), y	50.01 (12.39)
Gender, n (%)
Female	120 (58.3)
Male	86 (41.7)
BMI, mean (SD), kg/m^2	23.95 (3.88)
<23, n (%)	94 (45.6)
≥23, n (%)	45 (21.9)
≥25, n (%)	67 (32.5)
Diabetes mellitus, n (%)	17 (8.3)
HBeAg, n (%)
Positive	35 (17.0)
Negative	171 (83.0)
HBV DNA, median (range), IU/mL	4340 (20-271883036)
Biochemical markers
Total bilirubin, median (range), mg/dL	0.58 (0.19-3.53)
AST, median (range), U/L	26 (8-199)
≤1 x ULN, n (%)	171 (83.0)
>1 x ULN, n (%)	35 (17.0)
ALT, median (range), U/L	25 (5-166)
≤1 x ULN, n (%)	155 (75.2)
>1 x ULN, n (%)	51 (24.8)
ALP, median (range), U/L	65 (29-511)
Albumin, median (range), g/dL	4.40 (2.20-5.40)
INR, median (range)	1.00 (0.90-2.40)
WBC, median (range), /mm^3	6500 (2700-18900)
Hemoglobin, mean (SD), g/dL	13.13 (1.58)
Platelet, mean (SD), x10^9/L	220.00 (63.60)
Creatinine, mean (SD), mg/dL	1.14 (1.61)

kPa: Kilopascal; BMI: Body mass index; HBeAg: Hepatitis B e antigen;
AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; ULN: Upper limit of normal;
ALP: Alkaline phosphatase; INR: International normalized ratio.